FDA asks DNDN to unblind IMPACT now, absolutely logical The IMPACT started 4 years ago, should have at least additional 100-200 patients. DNDN can use this extra 100-200 patient data per FDA to support its claim
Congrats to May put buyers who had the balls to make that move. I may buy this at $3. I'm stuck holding some other shit biotech's though like AVNR and ACUS specifically. F me!